Publications

Export 1950 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C D E F G H I [J] K L M N O P Q R S T U V W X Y Z   [Show ALL]
U
Damankesh, A., J. Singh, F. Jahedpari, K. Shaalan, and F. Oroumchian, "Using Human Plausible Reasoning as a Framework for Multilingual Information Filtering", CLEF 2009 Workshop, in conjunction with ECDL2009, 13th European Conference on Digital Libraries, Corfu, Greece, 30 September , 2009. Abstractdamankesh-paper-clef2009.pdf

In this paper the application of the theory of Human Plausible Reasoning (HPR) has been investigated in the domain of filtering and cross language information retrieval. The theory of Human Plausible Reasoning first has been introduced by Collins and Michalski on early 1990s; it has been applied to IR since 1995. This work is an extension to those experiments which focuses on building a framework for cross language information retrieval. The system built in these experiments utilizes plausible inferences to infer new, unknown knowledge from existing knowledge to retrieve not only documents which are indexed by the query terms but also those which are plausibly relevant.

Salminen, J., S. - G. Jung, A. M. S. Kamel, J. M. Santos, and B. J. Jansen, "Using artificially generated pictures in customer-facing systems: an evaluation study with data-driven personas", Behaviour and Information Technology, vol. 41, no. 5: Taylor and Francis Ltd., pp. 905-921, 2022. AbstractWebsite

We conduct two studies to evaluate the suitability of artificially generated facial pictures for use in a customer-facing system using data-driven personas. STUDY 1 investigates the quality of a sample of 1,000 artificially generated facial pictures. Obtaining 6,812 crowd judgments, we find that 90% of the images are rated medium quality or better. STUDY 2 examines the application of artificially generated facial pictures in data-driven personas using an experimental setting where the high-quality pictures are implemented in persona profiles. Based on 496 participants using 4 persona treatments (2 × 2 research design), findings of Bayesian analysis show that using the artificial pictures in persona profiles did not decrease the scores for Authenticity, Clarity, Empathy, and Willingness to Use of the data-driven personas. © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Prats-Uribe, A., A. G. Sena, L. Y. H. Lai, W. - U. - R. Ahmed, H. Alghoul, O. Alser, T. M. Alshammari, C. Areia, W. Carter, P. Casajust, et al., "Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.", BMJ (Clinical research ed.), vol. 373, pp. n1038, 2021. Abstract

OBJECTIVE: To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents.

DESIGN: Multinational network cohort study.

SETTING: Hospital electronic health records from the United States, Spain, and China, and nationwide claims data from South Korea.

PARTICIPANTS: 303 264 patients admitted to hospital with covid-19 from January 2020 to December 2020.

MAIN OUTCOME MEASURES: Prescriptions or dispensations of any drug on or 30 days after the date of hospital admission for covid-19.

RESULTS: Of the 303 264 patients included, 290 131 were from the US, 7599 from South Korea, 5230 from Spain, and 304 from China. 3455 drugs were identified. Common repurposed drugs were hydroxychloroquine (used in from <5 (<2%) patients in China to 2165 (85.1%) in Spain), azithromycin (from 15 (4.9%) in China to 1473 (57.9%) in Spain), combined lopinavir and ritonavir (from 156 (<2%) in the VA-OMOP US to 2,652 (34.9%) in South Korea and 1285 (50.5%) in Spain), and umifenovir (0% in the US, South Korea, and Spain and 238 (78.3%) in China). Use of adjunctive drugs varied greatly, with the five most used treatments being enoxaparin, fluoroquinolones, ceftriaxone, vitamin D, and corticosteroids. Hydroxychloroquine use increased rapidly from March to April 2020 but declined steeply in May to June and remained low for the rest of the year. The use of dexamethasone and corticosteroids increased steadily during 2020.

CONCLUSIONS: Multiple drugs were used in the first few months of the covid-19 pandemic, with substantial geographical and temporal variation. Hydroxychloroquine, azithromycin, lopinavir-ritonavir, and umifenovir (in China only) were the most prescribed repurposed drugs. Antithrombotics, antibiotics, H2 receptor antagonists, and corticosteroids were often used as adjunctive treatments. Research is needed on the comparative risk and benefit of these treatments in the management of covid-19.

Chevli, K. K., M. Duff, P. Walter, C. Yu, B. Capuder, A. Elshafei, S. Malczewski, M. W. Kattan, and S. J. Jones, "Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy.", The Journal of urology, vol. 191, issue 6, pp. 1743-8, 2014 Jun. Abstract

PURPOSE: PCA3 is a urinary marker that has shown promise in predicting the presence of prostate cancer in men undergoing repeat prostate biopsy. We studied PCA3 before initial prostate biopsy.

MATERIALS AND METHODS: Records from a single organization were retrospectively reviewed. The predictive value of PCA3 was explored using nonparametric receiver operating characteristic curve analysis (ROC) and multivariable logistic regression analysis.

RESULTS: A total of 3,073 men underwent PCA3 analysis before initial prostate biopsy sampling of 12 to 14 areas. Mean PCA3 was 27.2 and 52.5 for patients without and with cancer, respectively. Prostate cancer was identified in 1,341 (43.6%) men. Overall 54.5% had Gleason 6 disease and 45.5% had Gleason 7 or greater (high grade prostate cancer). Mean PCA3 was 47.5 and 58.5 for the patients with Gleason 6 and 7 or greater disease, respectively. On multivariable logistic analysis PCA3 was statistically significantly associated with prostate cancer and high grade prostate cancer after adjusting for prostate specific antigen (p<0.001 for both), free prostate specific antigen (p=0.04 and p=0.01, respectively), age (p<0.001 for both), family history (p<0.001 and p=0.59, respectively), abnormal digital rectal examination (p=0.31 and p<0.001, respectively), prostate volume (p<0.001 for both) and body mass index (p<0.001 for both). Using ROC analysis PCA3 outperformed prostate specific antigen in the prediction of prostate cancer (AUC 0.697 vs 0.599, p<0.01) but not for high grade prostate cancer (AUC 0.682 vs 0.679, p=0.702).

CONCLUSIONS: PCA3 proved a useful tool in identifying patients at risk for prostate cancer before initial prostate biopsy. To our knowledge this is the largest PCA3 study in the initial biopsy population. These results suggest that further exploration of the value of PCA3 is warranted.

Chevli, K. K., M. Duff, P. Walter, C. Yu, B. Capuder, A. Elshafei, S. Malczewski, M. W. Kattan, and S. J. Jones, "Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy", The Journal of urology, vol. 191, no. 6: Elsevier, pp. 1743–1748, 2014. Abstract
n/a
Chevli, K. K., M. Duff, P. Walter, C. Yu, B. Capuder, A. Elshafei, S. Malczewski, M. W. Kattan, and S. J. Jones, "Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy", The Journal of urology, vol. 191, no. 6: Elsevier, pp. 1743–1748, 2014. Abstract
n/a
Feigin, V. L., R. V. Krishnamurthi, P. Parmar, B. Norrving, G. A. Mensah, D. A. Bennett, S. Barker-Collo, A. E. Moran, R. L. Sacco, T. Truelsen, et al., "Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study.", Neuroepidemiology, vol. 45, issue 3, pp. 161-76, 2015. Abstract

BACKGROUND: Global stroke epidemiology is changing rapidly. Although age-standardized rates of stroke mortality have decreased worldwide in the past 2 decades, the absolute numbers of people who have a stroke every year, and live with the consequences of stroke or die from their stroke, are increasing. Regular updates on the current level of stroke burden are important for advancing our knowledge on stroke epidemiology and facilitate organization and planning of evidence-based stroke care.

OBJECTIVES: This study aims to estimate incidence, prevalence, mortality, disability-adjusted life years (DALYs) and years lived with disability (YLDs) and their trends for ischemic stroke (IS) and hemorrhagic stroke (HS) for 188 countries from 1990 to 2013.

METHODOLOGY: Stroke incidence, prevalence, mortality, DALYs and YLDs were estimated using all available data on mortality and stroke incidence, prevalence and excess mortality. Statistical models and country-level covariate data were employed, and all rates were age-standardized to a global population. All estimates were produced with 95% uncertainty intervals (UIs).

RESULTS: In 2013, there were globally almost 25.7 million stroke survivors (71% with IS), 6.5 million deaths from stroke (51% died from IS), 113 million DALYs due to stroke (58% due to IS) and 10.3 million new strokes (67% IS). Over the 1990-2013 period, there was a significant increase in the absolute number of DALYs due to IS, and of deaths from IS and HS, survivors and incident events for both IS and HS. The preponderance of the burden of stroke continued to reside in developing countries, comprising 75.2% of deaths from stroke and 81.0% of stroke-related DALYs. Globally, the proportional contribution of stroke-related DALYs and deaths due to stroke compared to all diseases increased from 1990 (3.54% (95% UI 3.11-4.00) and 9.66% (95% UI 8.47-10.70), respectively) to 2013 (4.62% (95% UI 4.01-5.30) and 11.75% (95% UI 10.45-13.31), respectively), but there was a diverging trend in developed and developing countries with a significant increase in DALYs and deaths in developing countries, and no measurable change in the proportional contribution of DALYs and deaths from stroke in developed countries.

CONCLUSION: Global stroke burden continues to increase globally. More efficient stroke prevention and management strategies are urgently needed to halt and eventually reverse the stroke pandemic, while universal access to organized stroke services should be a priority. © 2015 S. Karger AG, Basel.

Zhang, S., F. Hu, S. - L. Jui, A. E. Hassanien, and K. Xiao, "Unsupervised Brain MRI Tumor Segmentation with Deformation-Based Feature", the 1st International Conference on Advanced Intelligent Systems and Informatics (AISI’15) Springer, Beni Suef University, Beni Suef, Eg, Nov. 28-30, 2015.
Zhang, S., F. Hu, S. - L. Jui, A. E. Hassanien, and K. Xiao, "Unsupervised Brain MRI Tumor Segmentation with Deformation-Based Feature", The 1st International Conference on Advanced Intelligent System and Informatics (AISI2015), November 28-30, 2015, Beni Suef, Egypt: Springer International Publishing, pp. 173–181, 2016. Abstract
n/a
Shihab, E., Z. M. Jiang, W. M. Ibrahim, B. Adams, and A. E. Hassan, "Understanding the impact of code and process metrics on post-release defects: a case study on the eclipse project", Proceedings of the 2010 ACM-IEEE International Symposium on Empirical Software Engineering and Measurement: ACM, pp. 4, 2010. Abstract
n/a
Alengebawy, A., B. A. Mohamed, N. Ghimire, K. Jin, T. Liu, M. Samer, and P. Ai, "Understanding the environmental impacts of biogas utilization for energy production through life cycle assessment: An action towards reducing emissions", Environmental Research, vol. DOI: https://doi.org/10.1016/j.envres.2022.113632, 2022.
Fu, J., A. T. Jalil, F. M. A. Altalbawy, T. Aljawahiry, H. Babur, I. M. Mohammed, R. S. Zabibah, L. Y. Qassem, and L. Baharinikoo, "Ultrasound-assisted dispersive solid-phase extraction for the preconcentration of dyes in water samples", Arabian Journal of Chemistry, vol. 16, pp. 105126, 2023.
T
Jamal, M. A., I. A. El-Khodary, and D. S. Ali, "A Two-Stage Rough Data Envelopment Analysis and Its Application in Three-Level Supply Chain Performance Evaluation", Ingénierie des Systèmes d’Information, vol. Vol. 27, issue No. 2, April, 2022, pp. 275-283, 2022.
Bantan, R., M. ELSEHETRY, A. S. Hassan, M. Elgarhy, D. Sharma, C. H. R. I. S. T. O. P. H. E. CHESNEAU, and F. A. R. R. U. K. H. JAMAL, "A Two-Parameter Model: Properties and Estimation under Ranked Sampling", mathematics, vol. 9, pp. 1-16, 2021. 16_mathematics-2752021.pdf
ASINS, M. A. R. I. A. J. O. S. É., I. Villalta, M. M. Aly, R. Olías, P. Alvarez De Morales, R. Huertas, J. Li, N. Jaime-Pérez, R. Haro, V. Raga, et al., "Two closely linked tomato HKT coding genes are positional candidates for the major tomato QTL involved in Na+ /K+ homeostasis.", Plant, cell & environment, vol. 36, issue 6, pp. 1171-91, 2013 Jun. Abstract

The location of major quantitative trait loci (QTL) contributing to stem and leaf [Na(+) ] and [K(+) ] was previously reported in chromosome 7 using two connected populations of recombinant inbred lines (RILs) of tomato. HKT1;1 and HKT1;2, two tomato Na(+) -selective class I-HKT transporters, were found to be closely linked, where the maximum logarithm of odds (LOD) score for these QTLs located. When a chromosome 7 linkage map based on 278 single-nucleotide polymorphisms (SNPs) was used, the maximum LOD score position was only 35 kb from HKT1;1 and HKT1;2. Their expression patterns and phenotypic effects were further investigated in two near-isogenic lines (NILs): 157-14 (double homozygote for the cheesmaniae alleles) and 157-17 (double homozygote for the lycopersicum alleles). The expression pattern for the HKT1;1 and HKT1;2 alleles was complex, possibly because of differences in their promoter sequences. High salinity had very little effect on root dry and fresh weight and consequently on the plant dry weight of NIL 157-14 in comparison with 157-17. A significant difference between NILs was also found for [K(+) ] and the [Na(+) ]/[K(+) ] ratio in leaf and stem but not for [Na(+) ] arising a disagreement with the corresponding RIL population. Their association with leaf [Na(+) ] and salt tolerance in tomato is also discussed.

AlKetbi, M., K. Polychronopoulou, A. F. Zedan, V. Sebastián, M. A. Baker, A. AlKhoori, M. A. Jaoude, O. Alnuaimi, S. S. Hinder, A. Tharalekshmy, et al., "Tuning the activity of Cu-containing rare earth oxide catalysts for CO oxidation reaction: Cooling while heating paradigm in microwave-assisted synthesis", Materials Research Bulletin, vol. 108: Elsevier, pp. 142–150, 2018. Abstract
n/a
AlKetbi, M., K. Polychronopoulou, A. F. Zedan, V. Sebastián, M. A. Baker, A. AlKhoori, M. A. Jaoude, O. Alnuaimi, S. S. Hinder, A. Tharalekshmy, et al., "Tuning the activity of Cu-containing rare earth oxide catalysts for CO oxidation reaction: Cooling while heating paradigm in microwave-assisted synthesis", Materials Research Bulletin, vol. 108: Elsevier, pp. 142–150, 2018. Abstract

n/a

Jori, G., "Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy", Journal of Photochemistry and photobiology B: Biology, vol. 36, issue 2: Elsevier, pp. 87-93, 1996. Abstract
n/a
Davis, E. E., Q. Zhang, Q. Liu, B. H. Diplas, L. M. Davey, J. Hartley, C. Stoetzel, K. Szymanska, G. Ramaswami, C. V. Logan, et al., "TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum", Nature Genetics, vol. 43, issue 3, pp. 189–196, 2011.
Hassan, M. A., H. W. Palm, M. A. Mahmoud, and F. A. Jama, "Trypanorhynch cestodes from the musculature of commercial fishes from the Arabian gulf", Arab Gulf Journal of Scientific Research, vol. 20, issue 2, pp. 74-86, 2002. cestodes.pdf
Agamy, E., A. Bento, B. Hafez, S. A. Hassan, E. Hegazi, A. Herz, T. Jardak, M. Ksantini, M. Konstantopoulou, and B. Mazomenos, Triphelio–an international research project for sustainable control of lepidopterous pests in olive groves., , 2003. Abstract
n/a
Herz, A., S. A. Hassan, B. Hafez, E. Hegazi, F. Nasr, A. Youssef, E. A. Agamy, T. Jardak, M. Ksantini, and M. Konstantopoulou, "TRIPHELIO - an international research project for sustainable control of Lepidopteous pests in olive groves.", XXII International Congress of Entomology, 15-21 August, Brisbane, Queensland, Australia., 2004. Abstract
n/a
Bourne, R., J. D. Steinmetz, S. Flaxman, P. S. Briant, H. R. Taylor, S. Resnikoff, R. J. Casson, A. Abdoli, E. Abu-Gharbieh, A. Afshin, et al., "Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study", The Lancet Global Health, issue 20, pp. 1 - 14, 2020/12//. AbstractWebsite
n/a